Drugs / JY509 universal NK cell injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07406178 | Jan 2026 → Jan 2029 expected | B-cell childhood acute lymphoblastic leukemia | Institute of Hematology & Blood Diseases Hospital, China | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JY509 universal NK cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07406178 ↗ |
| Modality | Cell therapy | “JY509 universal NK cell injection” NCT07406178 ↗ |